247 related articles for article (PubMed ID: 17518432)
21. Functional conservation of phosphorylation-specific prolyl isomerases in plants.
Yao JL; Kops O; Lu PJ; Lu KP
J Biol Chem; 2001 Apr; 276(17):13517-23. PubMed ID: 11118438
[TBL] [Abstract][Full Text] [Related]
22. Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products.
Takahashi K; Shimizu T; Kosaka K; Hidaka M; Uchida C; Uchida T
Curr Drug Targets; 2014; 15(10):973-81. PubMed ID: 25182609
[TBL] [Abstract][Full Text] [Related]
23. Peptide binding induces large scale changes in inter-domain mobility in human Pin1.
Jacobs DM; Saxena K; Vogtherr M; Bernado P; Pons M; Fiebig KM
J Biol Chem; 2003 Jul; 278(28):26174-82. PubMed ID: 12686540
[TBL] [Abstract][Full Text] [Related]
24. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.
Stifani S
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30314361
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors.
Du L; Wang X; Cui G; Xu B
Bioorg Med Chem; 2021 Jan; 29():115878. PubMed ID: 33246256
[TBL] [Abstract][Full Text] [Related]
26. Peptidyl-prolyl isomerase inhibitors.
Wang XJ; Etzkorn FA
Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169
[TBL] [Abstract][Full Text] [Related]
27. 1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides.
Wintjens R; Wieruszeski JM; Drobecq H; Rousselot-Pailley P; Buée L; Lippens G; Landrieu I
J Biol Chem; 2001 Jul; 276(27):25150-6. PubMed ID: 11313338
[TBL] [Abstract][Full Text] [Related]
28. [Recent advances in the study of pin1 and its inhibitors].
Zhang CJ; Zhang ZH; Xu BL; Wang YL
Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
[TBL] [Abstract][Full Text] [Related]
29. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
[TBL] [Abstract][Full Text] [Related]
30. Complete thermodynamic and kinetic characterization of the isomer-specific interaction between Pin1-WW domain and the amyloid precursor protein cytoplasmic tail phosphorylated at Thr668.
De S; Greenwood AI; Rogals MJ; Kovrigin EL; Lu KP; Nicholson LK
Biochemistry; 2012 Oct; 51(43):8583-96. PubMed ID: 23025283
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of the novel elemonic acid derivatives as Pin1 inhibitors.
Li X; Li L; Zhou Q; Zhang N; Zhang S; Zhao R; Liu D; Jing Y; Zhao L
Bioorg Med Chem Lett; 2014 Dec; 24(24):5612-5615. PubMed ID: 25466185
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Pin1 peptidyl-prolyl cis/trans isomerase activity by its WW binding module on a multi-phosphorylated peptide of Tau protein.
Smet C; Wieruszeski JM; Buée L; Landrieu I; Lippens G
FEBS Lett; 2005 Aug; 579(19):4159-64. PubMed ID: 16024016
[TBL] [Abstract][Full Text] [Related]
33. Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1.
Tatara Y; Lin YC; Bamba Y; Mori T; Uchida T
Biochem Biophys Res Commun; 2009 Jul; 384(3):394-8. PubMed ID: 19422802
[TBL] [Abstract][Full Text] [Related]
34. Targeting Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1: A Structure-based Virtual Screening Approach to Find Novel Inhibitors.
da Costa KS; Galúcio JM; de Jesus DA; Gomes GC; Lima E Lima AH; Taube PS; Dos Santos AM; Lameira J
Curr Comput Aided Drug Des; 2020; 16(5):605-617. PubMed ID: 31654518
[TBL] [Abstract][Full Text] [Related]
35. Structural basis for phosphoserine-proline recognition by group IV WW domains.
Verdecia MA; Bowman ME; Lu KP; Hunter T; Noel JP
Nat Struct Biol; 2000 Aug; 7(8):639-43. PubMed ID: 10932246
[TBL] [Abstract][Full Text] [Related]
36. Modulating the Affinities of Phosphopeptides for the Human Pin1 WW Domain Using 4-Substituted Proline Derivatives.
Huang KY; Horng JC
Biochemistry; 2015 Oct; 54(40):6186-94. PubMed ID: 26406962
[TBL] [Abstract][Full Text] [Related]
37. Peroxide-mediated oxidation and inhibition of the peptidyl-prolyl isomerase Pin1.
Innes BT; Sowole MA; Gyenis L; Dubinsky M; Konermann L; Litchfield DW; Brandl CJ; Shilton BH
Biochim Biophys Acta; 2015 May; 1852(5):905-12. PubMed ID: 25595659
[TBL] [Abstract][Full Text] [Related]
38. Aryl indanyl ketones: efficient inhibitors of the human peptidyl prolyl cis/trans isomerase Pin1.
Daum S; Erdmann F; Fischer G; Féaux de Lacroix B; Hessamian-Alinejad A; Houben S; Frank W; Braun M
Angew Chem Int Ed Engl; 2006 Nov; 45(44):7454-8. PubMed ID: 17048295
[No Abstract] [Full Text] [Related]
39. An essential role for Pin1 in Xenopus laevis embryonic development revealed by specific inhibitors.
Wildemann D; Hernandez Alvarez B; Stoller G; Zhou XZ; Lu KP; Erdmann F; Ferrari D; Fischer G
Biol Chem; 2007 Oct; 388(10):1103-11. PubMed ID: 17937625
[TBL] [Abstract][Full Text] [Related]
40. The Peptidyl-Prolyl
Anto NP; Muraleedharan A; Nath PR; Sun Z; Keasar C; Livneh E; Braiman A; Altman A; Kong KF; Isakov N
Front Immunol; 2023; 14():1126464. PubMed ID: 36969236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
